SEC Comment Letter 0000000000-24-001096 to Boundless Bio, Inc. (BOLD)
Boundless Bio, Inc.
Date: Jan. 29, 2024 · CIK: 0001782303 · Accession: 0000000000-24-001096
AI Filing Summary & Sentiment
Letter
United States securities and exchange commission logo January 29, 2024 Zachary Hornby President and Chief Executive Officer Boundless Bio, Inc. 9880 Campus Point Drive, Suite 120 San Diego, CA 92121 Re:Boundless Bio, Inc. Amendment No. 2 to Draft Registration Statement on Form S-1 Submitted January 23, 2024 CIK No. 0001782303 Dear Zachary Hornby: We have reviewed your amended draft registration statement and have the following comment. Please respond to this letter by providing the requested information and either submitting an amended draft registration statement or publicly filing your registration statement on EDGAR. If you do not believe our comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing the information you provide in response to this letter and your amended draft registration statement or filed registration statement, we may have additional comments. Amendment No. 2 to Draft Registration Statement on Form S-1 Prospectus Summary Our Pipeline and Platform, page 3 1.Please revise your pipeline table here and elsewhere in the registration statement so that it contains no more than two preclinical columns that show a progress bar. Please contact Ibolya Ignat at 202-551-3636 or Vanessa Robertson at 202-551-3649 if you have questions regarding comments on the financial statements and related matters. Please contact Daniel Crawford at 202-551-7767 or Alan Campbell at 202-551-4224 with any other questions.
FirstName LastNameZachary Hornby Comapany NameBoundless Bio, Inc. January 29, 2024 Page 2 FirstName LastName Zachary Hornby Boundless Bio, Inc. January 29, 2024 Page 2 Sincerely, Division of Corporation Finance Office of Life Sciences cc: Matthew Bush, Esq.
Show Raw Text
United States securities and exchange commission logo
January 29, 2024
Zachary Hornby
President and Chief Executive Officer
Boundless Bio, Inc.
9880 Campus Point Drive, Suite 120
San Diego, CA 92121
Re:Boundless Bio, Inc.
Amendment No. 2 to Draft Registration Statement on Form S-1
Submitted January 23, 2024
CIK No. 0001782303
Dear Zachary Hornby:
We have reviewed your amended draft registration statement and have the following
comment.
Please respond to this letter by providing the requested information and either submitting
an amended draft registration statement or publicly filing your registration statement on
EDGAR. If you do not believe our comment applies to your facts and circumstances or do not
believe an amendment is appropriate, please tell us why in your response.
After reviewing the information you provide in response to this letter and your amended
draft registration statement or filed registration statement, we may have additional comments.
Amendment No. 2 to Draft Registration Statement on Form S-1
Prospectus Summary
Our Pipeline and Platform, page 3
1.Please revise your pipeline table here and elsewhere in the registration statement so that it
contains no more than two preclinical columns that show a progress bar.
Please contact Ibolya Ignat at 202-551-3636 or Vanessa Robertson at 202-551-3649 if
you have questions regarding comments on the financial statements and related matters. Please
contact Daniel Crawford at 202-551-7767 or Alan Campbell at 202-551-4224 with any other
questions.
FirstName LastNameZachary Hornby
Comapany NameBoundless Bio, Inc.
January 29, 2024 Page 2
FirstName LastName
Zachary Hornby
Boundless Bio, Inc.
January 29, 2024
Page 2
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Matthew Bush, Esq.